Working at the intersection of genomics, cancer biology, molecular diagnostics and personalised healthcare.
Shansons Precix is a precision medicine-focused organisation working at the intersection of genomics, cancer biology, molecular diagnostics and personalised healthcare.
Our scientific direction is centred on understanding disease at the molecular and genetic level and translating that understanding into approaches that can support more personalised healthcare decisions.
We focus particularly on cancer, where differences between patients and between individual tumours can have a profound impact on diagnosis, treatment response and disease progression.
Through precision diagnostics, genomic technologies and research-driven approaches, we aim to contribute to a healthcare model where the right information can support the right decision for the right patient.
To advance precision medicine by developing innovative approaches that combine genomic science, molecular diagnostics, computational biology and personalised healthcare research.
We aim to contribute to a healthcare future where disease is understood earlier, treatment decisions become more informed and medical strategies increasingly reflect the biology of the individual.
A future where every patient can be understood at the molecular level.
We envision a healthcare ecosystem where genetic and molecular information can complement conventional clinical information to support:
We believe the next generation of healthcare will be driven by the ability to understand disease at an increasingly precise biological level.
Study the molecular and genetic characteristics underlying disease biology.
Identify clinically and biologically relevant biomarkers and alterations.
Convert complex genomic information into meaningful biological insights.
Use individual-level information to support more personalised healthcare strategies.
Translate research and technological progress into practical precision medicine applications.
From Trial-and-Error to Data-Driven Medicine.
Traditional medicine has transformed healthcare, but many diseases remain biologically complex. Patients with the same diagnosis may respond differently to the same treatment.
Because disease is not always defined by diagnosis alone. Underlying differences in:
can influence individual outcomes. Personalised medicine seeks to incorporate these differences into healthcare decision-making, specifically positioned around individual genetic characteristics for disease susceptibility, detection, treatment customisation and drug selection.
The long-term value of scientific research lies in translating discoveries into meaningful applications:
